北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (4): 630-633. doi: 10.3969/j.issn.1671-167X.2018.04.010

• 论著 • 上一篇    下一篇

单中心16年青年膀胱尿路上皮癌患者的诊治

唐兴国1*#,颜野1*,邱敏1△,卢剑1,陆敏2,侯小飞1,黄毅1,马潞林1   

  1. (北京大学第三医院1.泌尿外科, 2.病理科, 北京100191)
  • 出版日期:2018-08-18 发布日期:2018-08-18
  • 通讯作者: 邱敏 E-mail:qm1868@sina.com

Retrospective study of young bladder urothelial carcinoma from a single center within 16 years

TANG Xing-guo1*#, YAN Ye1*, QIU Min1△, LU Jian1, LU Min2, HOU Xiao-fei1, HUANG Yi1, MA Lu-lin1   

  1. (1. Department of Urology, 2. Department of Pathology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2018-08-18 Published:2018-08-18
  • Contact: QIU Min E-mail:qm1868@sina.com

摘要: 目的:研究40岁及以下青年膀胱尿路上皮癌患者的临床表现、临床分期、病理分级、治疗及预后等情况。方法:选择 2001年1月至2016年12月北京大学第三医院泌尿外科收治的43例40岁及以下的膀胱癌患者临床资料进行回顾性分析。结果:本组病例占同期科室收治的膀胱癌患者的2.2%,男性35例,女性8例,平均年龄33岁(23~40岁)。初诊时以无痛性肉眼血尿为主要症状者27例(62.8%), 体检发现异常者9例(20.9%),以膀胱刺激症状或排尿异常起病者7例(16.3%)。肿瘤单发者34例(79.1%),多发者9例(20.9%),且多发者均在31~40岁亚组。根据患者临床分期采用相应的手术方式治疗。 术后病理分级:低级别乳头状尿路上皮癌29例(67.4%),高级别乳头状尿路上皮癌14例(32.6%)。Ta期31例(72.1%),T1期7例(16.3%), T3期1例(2.3%), T4期3例(7.0%),T1期合并Tis 1例(2.3%)。术后3例失访,另40例随访5~165个月,随访患者中有5例复发,复发率12.5%(5/40), 平均复发时间39个月(3~105个月), 2例患者进展,进展率5%(2/40)。多发患者组复发率33%(3/9),单发患者组复发率5.9%(2/34),两组差异具有统计学意义(P=0.000 3)。结论:青年膀胱癌的发病比例呈增长趋势, 无痛性肉眼血尿是青年膀胱癌的主要临床表现,但青年患者的下尿路刺激症状同样需警惕肿瘤的发生,术后的复发情况可能与多发病变有关。

关键词:  , 膀胱癌, 青年, 预后

Abstract: Objective: To evaluate the clinical and pathological features, treatment and prognosis for bladder urothelial carcinoma in relative young patients under 40 years. Methods: A retrospective study involved a total of 43 consecutive patients of bladder urothelial carcinoma, which were under 40 years old from January 2001 to December 2016. Results: The incidence rate of bladder urothelial carcinoma in the patients under 40 years was 2.2%, and 35 males and 8 females were included. The average age was 33 years (ranging from 23 to 40 years). At initial visit, 62.8% of the patients presented with painless gross hematuria, 9 patients were discovered by routine examination, and 7 patients experienced lower urinary tract symptoms. Solitary tumor occurred in 34 cases whereas multiple carcinomas had been discovered in 9 cases,and all the 9 multiple cases were from 31-40-year-old subgroups. All the patients received proper surgical intervention according to their own clinical stages. Post-operative pathological results showed 29 low-grade urothelial carcinoma and 14 high-grade cases which included 31 Ta cases, with 7 cases of T1, 1 case of T3, and 3 cases of T4 and one case of T1 plus Tis. The total follow-up was from 5 to 165 months,3 cases were lost. The overall recurrence rate was 12.5% (5 cases from 40). One patient developed distal metastasis, one died of metastasis after 13 months, and the other three received secondary trans-urethral resection of bladder tumors. The average recurrence time was 39 months (rang-ing from 3 to 105 months). The progression rate was 5% among all the followedup patients (2 cases from 40). The recurrence rate in multiple lesions group (33%, 3/9) was significantly higher than that (5.9%, 2/34) in solitary lesion group (P=0.000 3). Conclusion: The incidence rate of bladder urothelial carcinoma in young patients under 40 years becomes increasingly higher over years. The major initial presentation is painless gross hematuria among these young patients, but lower urinary tract symptoms should also be noticed for young patients to rule out tumor. Postoperative tumor recurrence might be associated with multiple lesions, which is not related to the tumor size or pathological features.

Key words: Bladder urothelial carcinoma, Young, Prognosis

中图分类号: 

  • R694
[1] 张铃福, 陈明, 赵小宇, 王港, 崔龙, 凌晓锋, 王立新, 徐智, 郭丽梅, 侯纯升. 原发灶局限于胆囊壁内胆囊癌大体分型及其与预后和癌前病变的相关性[J]. 北京大学学报(医学版), 2026, 58(1): 184-189.
[2] 高雅静, 李正芳, 马梦思, 武丽君. SII和SIRI对白塞病葡萄膜炎的风险预测及疾病活动度和预后的评估[J]. 北京大学学报(医学版), 2025, 57(6): 1067-1073.
[3] 李慎谟, 苏丹丹, 林己煜, 宋昊东, 马潞林, 侯小飞, 王国良, 张洪宪, 叶剑飞, 张树栋. 腹腔镜下膀胱癌根治术同期行肾输尿管全长切除术的预后分析[J]. 北京大学学报(医学版), 2025, 57(5): 961-966.
[4] 郭博达, 陆敏, 王国良, 张洪宪, 刘磊, 侯小飞, 赵磊, 田晓军, 张树栋. 肾透明细胞癌与非透明细胞癌伴静脉癌栓患者的临床病理特征及预后比较[J]. 北京大学学报(医学版), 2025, 57(4): 644-649.
[5] 缪祺, 洪保安, 张学舟, 孙志鹏, 王维, 王宇轩, 薄予轩, 赵佳晖, 张宁. 膀胱癌合并冠心病患者行经尿道膀胱肿瘤切除术围手术期抗血小板药物管理[J]. 北京大学学报(医学版), 2025, 57(4): 698-703.
[6] 李伟浩, 李晶, 张学民, 李伟, 李清乐, 张小明. 术中回收式自体输血对颈动脉体瘤切除术后肿瘤预后的影响[J]. 北京大学学报(医学版), 2025, 57(2): 272-276.
[7] 毛雅晴, 陈震, 于尧, 章文博, 刘洋, 彭歆. 2型糖尿病对口腔鳞状细胞癌患者预后的影响[J]. 北京大学学报(医学版), 2024, 56(6): 1089-1096.
[8] 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588.
[9] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[10] 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666.
[11] 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679.
[12] 方杨毅,李强,黄志高,陆敏,洪锴,张树栋. 睾丸鞘膜高分化乳头状间皮肿瘤1例[J]. 北京大学学报(医学版), 2024, 56(4): 741-744.
[13] 曾媛媛,谢云,陈道南,王瑞兰. 脓毒症患者发生正常甲状腺性病态综合征的相关因素[J]. 北京大学学报(医学版), 2024, 56(3): 526-532.
[14] 吴一凡,玉应香,谢岚,张志达,常翠青. 不同体重指数青年男性的静息能量消耗特点及预测方程评价[J]. 北京大学学报(医学版), 2024, 56(2): 247-252.
[15] 苏俊琪,王晓颖,孙志强. 舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证[J]. 北京大学学报(医学版), 2024, 56(1): 120-130.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!